98%
921
2 minutes
20
Background And Objective: Nasopharyngeal carcinoma (NPC) is a rare disease in most parts of the world, but it is highly prevalent in South China. Epstein-Barr virus (EBV) is one of the major risk factors for NPC. Hence, understanding the factors associated with the reactivation of EBV from the latent stage is crucial for preventing NPC. This study aimed to investigate the risk factors for EBV reactivation associated with NPC in high-prevalence areas in China using a Bayesian network (BN) model combined with structural equation modeling tools.
Methods: The baseline information for this study was derived from NPC screening data from a population-based prospective cohort in Sihui City, Guangdong Province, China. We divided the data into a training dataset and a test dataset. We then constructed an interaction networktionba BN prediction model to explore the risk factors for EBV reactivation, which was compared with a conventional logistic regression model.
Results: A total of 12,579 participants were included in the analyses, with 1596 participant pairs finally included after the use of a nested case-control study. The results of multivariable logistic regression showed that only being older than 60 years (OR = 1.718, 95% CI = 1.273,2.322) and being a current smoker (OR = 1.477, 95% CI = 1.167 - 1.872) were the risk factors for EBV reactivation. The results of the model constructed using BN showed that age and smoking were directly associated with EBV reactivation. In contrast, sex, education level, tea drinking, cooking, and family history of cancer were indirectly associated with EBV reactivation. Further, we predicted the risk of EBV reactivation using Bayesian inference and visualized the BN inference. Model prediction performance was evaluated using the test dataset. The results showed that the BN model slightly outperformed the traditional logistic regression model in all metrics.
Conclusions: BN not only reflects the complex interaction between factors but also visualizes the prediction results. It has a promising application potential in the risk prediction of EBV reactivation associated with NPC.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11790440 | PMC |
http://dx.doi.org/10.3389/fonc.2024.1369765 | DOI Listing |
J Med Virol
September 2025
Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are oncogenic human gammaherpesviruses (GHVs) associated with a broad spectrum of malignancies and chronic diseases. However, direct studies of these viruses in humans are limited by ethical constraints, technical challenges, and their strict species specificity. To overcome these barriers, researchers have developed surrogate models, with murine gammaherpesvirus 68 (MHV68) emerging as a tractable and widely utilized system.
View Article and Find Full Text PDFJ Infect Dev Ctries
August 2025
Gastroenterology Division, Internal Medicine Department, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (UMC), Muscat, Sultanate of Oman.
Introduction: Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivation are known complications in immunocompromised hosts, particularly transplant recipients. However, their occurrence and clinical implications in patients with solid tumors remain underexplored. The introduction of immune checkpoint inhibitors (ICIs) has transformed cancer therapy, but immune-related adverse events (irAEs), including colitis, are increasingly recognized.
View Article and Find Full Text PDFImmunol Lett
September 2025
Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki,
Background: COVID-19 is still a significant health concern worldwide. B cell responses to COVID-19 have been extensively studied in acute severe disease, but less so during extended follow-up or mild disease. Persisting immunological changes together with herpesvirus reactivations during acute COVID-19 have been suggested as contributing factors for post-acute sequelae of COVID-19 (PASC).
View Article and Find Full Text PDFFront Immunol
September 2025
School of Medicine, Nankai University, Tianjin, China.
Purpose: Relapse remains the leading cause of treatment failure in high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome-IB (MDS-IB) patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ruxolitinib has demonstrated antileukemic activity , and decitabine has been found to be tolerable when combined with modified busulfan-cyclophosphamide (mBu/Cy) conditioning regimen. Here, we investigated the efficacy of ruxolitinib and decitabine plus a mBu/Cy conditioning regimen (Rux-Dec-mBu/Cy) in reducing relapse in high-risk AML/MDS patients ().
View Article and Find Full Text PDFMicroorganisms
August 2025
Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Periodontal diseases in pediatric subjects represent a challenging and relatively underexplored area compared to the extensive data available about periodontal diseases in adults. The present narrative review aims to explore the periodontal status and the related subgingival and/or salivary microbial profiles in pediatric subjects (≤18 years), focusing also on the state of health or systemic diseases. In healthy periodontium, early colonizers, such as and spp.
View Article and Find Full Text PDF